Table 3.
Survivors (n=29) | Non-survivors (n=10) | p value | |
---|---|---|---|
Median age (years with IQR) | 2 (0.8; 14) | 8.5 (0.25; 16.8) | 0.85 |
Gender (n, %) | |||
Male | 11 (38 %) | 5 (50 %) | 0.70 |
Female | 18 (62 %) | 5 (50 %) | |
Race (n, %) | |||
White | 7 (24 %) | 1 (10 %) | 0.60 |
African American | 15 (52 %) | 5 (50 %) | 1.0 |
Latin American | 7 (24 %) | 3 (30 %) | 0.63 |
Asian American | 0 (0 %) | 1 (10 %) | nd |
PRISM II score Median (IQR) | 9 (5; 12) | 7 (4.25; 11.25) | 0.46 |
Length of stay in ICU Median (IQR) | 18.5 (16.5; 26) | 13 (10; 24) | 0.20 |
Serum creatinine Mean ± SD, peak mg/dl | 1.6±1.4 | 1.5±1.8 | 0.30 |
AKI (n, %) | 12 (41 %) | 7 (70 %) | 0.15 |
Required CRRT (n, %) | 8 (27 %) | 4 (40 %) | 0.70 |
Treated with ECMO (n, %) | 6 (21 %) | 4 (40 %) | 0.70 |
IQR inter-quartile range; ICU intensive care unit; AKI acute kidney injury; CRRT continuous renal replacement therapy; ECMO extracorporeal membrane oxygenation